Industry and the WHO Network on Antimicrobial Resistance Monitoring: Opportunities for Collaboration. Based on presentations and discussion at the Joint WHO/IFPMA Information Meeting. Geneva, 12-13 November 1996
(1997; 13 pages)

Abstract

Since the introduction of the first effective antimicrobial drugs many different chemical classes of molecule of natural, semi-synthetic or synthetic origin have been exploited for their selective toxicity.

After the discovery of sulphonamides and penicillin earlier this century, the years between 1940 and 1970 saw the >golden age= of discovery of new antibacterial agents. As a result, many infections which were once serious and potentially fatal can now be treated and cured.

However, such past successes have encouraged the overuse and misuse of antibiotics. The result: the emergence of resistance on a global scale. Microorganisms are not easily outwitted and subsequent to the introduction of each new antimicrobial drug, sooner or later, drug-resistant strains (and opportunist pathogens innately resistant to the drugs) have emerged.

 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: June 25, 2014